BioCentury | Aug 22, 2019
Company News

Aug. 21 Company Quick Takes: GSK, FibroGen take regulatory steps forward for HIF-PH inhibitors in Asia; plus Xtandi, Biotheus/Alligator and more

...CMAB to manufacture Kintor’s ACVRL1 antibody CDMO company CMAB Biopharma Inc. (Suzhou, China) partnered with Suzhou Kintor Pharmaceuticals Inc....
BioCentury | Mar 30, 2018
Company News

Management tracks: Pacira, Suzhou Kintor

...Scott Braunstein has left the company. CEO David Stack will assume his duties. Cancer company Suzhou Kintor Pharmaceuticals Inc....
BioCentury | Feb 2, 2018
Company News

Pfizer, Kintor in deal for ACVRL1 mab

...Pfizer Inc. (NYSE:PFE) granted Suzhou Kintor Pharmaceuticals Inc. (Suzhou, China) exclusive, worldwide rights to develop and commercialize PF-03446962 (PF-3446962...
...financial terms, and Pfizer did not respond to inquiries. Pfizer Inc. (NYSE:PFE), New York, N.Y. Suzhou Kintor Pharmaceuticals Inc....
BioCentury | Jan 19, 2018
Financial News

China's Kintor, Zelgen complete financings

...kinase inhibitor in testing to treat various cancers. Suzhou Zelgen Biopharmaceuticals Co. Ltd., Kunshan, China Suzhou Kintor Pharmaceuticals Inc....
BioCentury | Jan 16, 2018
Financial News

China's Kintor, Zelgen complete financings

Suzhou Kintor Pharmaceuticals Inc. (Suzhou, China) and Suzhou Zelgen Biopharmaceuticals Co. Ltd. (Suzhou, China) each completed financings, raising more than $100 million combined. Kintor raised RMB288 million ($44.7 million) on Jan. 11 in a series...
Items per page:
1 - 5 of 5
BioCentury | Aug 22, 2019
Company News

Aug. 21 Company Quick Takes: GSK, FibroGen take regulatory steps forward for HIF-PH inhibitors in Asia; plus Xtandi, Biotheus/Alligator and more

...CMAB to manufacture Kintor’s ACVRL1 antibody CDMO company CMAB Biopharma Inc. (Suzhou, China) partnered with Suzhou Kintor Pharmaceuticals Inc....
BioCentury | Mar 30, 2018
Company News

Management tracks: Pacira, Suzhou Kintor

...Scott Braunstein has left the company. CEO David Stack will assume his duties. Cancer company Suzhou Kintor Pharmaceuticals Inc....
BioCentury | Feb 2, 2018
Company News

Pfizer, Kintor in deal for ACVRL1 mab

...Pfizer Inc. (NYSE:PFE) granted Suzhou Kintor Pharmaceuticals Inc. (Suzhou, China) exclusive, worldwide rights to develop and commercialize PF-03446962 (PF-3446962...
...financial terms, and Pfizer did not respond to inquiries. Pfizer Inc. (NYSE:PFE), New York, N.Y. Suzhou Kintor Pharmaceuticals Inc....
BioCentury | Jan 19, 2018
Financial News

China's Kintor, Zelgen complete financings

...kinase inhibitor in testing to treat various cancers. Suzhou Zelgen Biopharmaceuticals Co. Ltd., Kunshan, China Suzhou Kintor Pharmaceuticals Inc....
BioCentury | Jan 16, 2018
Financial News

China's Kintor, Zelgen complete financings

Suzhou Kintor Pharmaceuticals Inc. (Suzhou, China) and Suzhou Zelgen Biopharmaceuticals Co. Ltd. (Suzhou, China) each completed financings, raising more than $100 million combined. Kintor raised RMB288 million ($44.7 million) on Jan. 11 in a series...
Items per page:
1 - 5 of 5